464TiP Phase III study of adjuvant encorafenib plus binimetinib vs placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design
| Autor: | van Akkooi, A.C.J., Hauschild, A., Long, G.V., Mandala, M., Kicinski, M., Govaerts, A-S., Klauck, I., Ouali, M., Lorigan, P., Eggermont, A.M.M. |
|---|---|
| Zdroj: | In Annals of Oncology November 2022 33 Supplement 9:S1617-S1618 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|